| CrimsonCanary Competitor Pipelines |
CrimsonCanary Competitor Pipelines are detailed pipelines including scientific and marketing information on lead compounds (Sample page) and a comprehensive table of patents and research activities (Sample page). All information is hyperlinked to sources wherever possible for validation. We realise that information is only any good if it is current and therefore all our pipelines are updated quarterly. |
|||||
Buy one time only |
Buy with quarterly updates for one year (see individual reports for update schedule) |
||||
| COT kinase (TPL2) inhibitors (See Table of Contents) Update schedule: Mar/Jun/Sep/Dec |
$150 |
$300 |
|||
| FAK kinase inhibitors New!
See Table of Contents) Update schedule: Feb/May/Aug/Nov |
$400 |
$800 |
|||
| PIM kinase inhibitors New!
See Table of Contents) Update schedule: Feb/May/Aug/Nov |
$300 |
$600 |
|||
| Polo like kinase inhibitors Updated! (includes PLK1, PLK2, PLK3, PLK4. See Table of Contents) Update schedule: Feb/May/Aug/Nov |
$600 |
$1200 |
|||
| Rho kinase inhibitors (includes ROCK1 and ROCK2. See Table of Contents) Update schedule: Mar/Jun/Sep/Dec |
$800 |
$1600 |
|||
Reports will be emailed out in PDF format within 24 hours of receiving payment. If you have chosen the option to buy quarterly updates then you will automatically receive an update every quarter after initially purchased. Email sales@crimsoncanary.com if you would prefer to be invoiced for the reports. Terms of Use
For questions about CrimsonCanary reports, to suggest a target for analysis or to discuss custom client based work please email: info@crimsoncanary.com |
The report is 11 pages long